Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60

BMC Public Health
Cornelia BetschKonrad Reinhart

Abstract

Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interventions are needed that take theory-based specific determinants of vaccination behaviour into account. Moreover, message and campaign design should consider specific age-related characteristics (e.g., information processing, media use). The aim of this study is (i) to identify the specific informational and interventional needs of this risk group, (ii) to design and implement a targeted intervention aiming to decrease vaccine hesitancy, increase vaccine uptake and decrease the health and economic burden due to the respective diseases, and (iii) to measure the effect of this evidence-informed intervention on various levels. Prospective, multi-methods intervention study targeting individuals aged ≥60 years in a model region in Germany (federal state of Thuringia, 500,000 inhabitants ≥60 years old). The development of the intervention follows theory-based and evidence-informed principles: Data from a cross-sectional representative study provide insi...Continue Reading

References

Aug 1, 1989·The Gerontologist·K W Schaie
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David N FismanJennifer Daley
Feb 7, 2008·The Cochrane Database of Systematic Reviews·S A MoberleyR M Andrews
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristin L NicholEdward Ehlinger
Jan 6, 2009·Critical Care Medicine·Francesca M RubulottaUNKNOWN Society of Critical Care Medicine
Sep 20, 2011·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·David R RoalfJeri S Janowsky
Oct 26, 2011·Annals of the New York Academy of Sciences·Rui MataRalph Hertwig
Mar 27, 2012·Vaccine·Alexandra Zingg, Michael Siegrist
Apr 16, 2013·Human Vaccines & Immunotherapeutics·Eve DubéJulie Bettinger
Sep 24, 2013·Vaccine·Samuel K PeasahMarc-Alain Widdowson
Nov 7, 2013·Human Vaccines & Immunotherapeutics·Thorsten RieckOle Wichmann
Feb 18, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olga Ochoa-GondarImma Hospital-Guardiola
Dec 11, 2014·Journal of Health Communication·Nancy Grant HarringtonLewis Donohew
Apr 22, 2015·Vaccine·Noni E MacDonald, UNKNOWN SAGE Working Group on Vaccine Hesitancy
May 2, 2015·Human Vaccines & Immunotherapeutics·S DirmesropianA T Newall
Mar 1, 2007·Perspectives on Psychological Science : a Journal of the Association for Psychological Science·Ellen PetersCorinne Auman
Feb 13, 2016·Cognitive, Affective & Behavioral Neuroscience·Michael J TobiaTobias Sommer
Mar 10, 2016·Journal of Health Communication·Ashley E AnkerCarolyn A Lagoe
Sep 30, 2016·Expert Review of Vaccines·Barbara Rita PorchiaSara Boccalini
Mar 2, 2017·International Journal of Molecular Sciences·Shigehisa YanagiMasamitsu Nakazato
Jun 15, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Pieter T de BoerMaarten J Postma
Jun 29, 2017·The New England Journal of Medicine·Konrad ReinhartSimon Finfer

❮ Previous
Next ❯

Citations

Aug 2, 2019·PloS One·Mark van der LindenStephanie Perniciaro
Feb 26, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Cornelia BetschRobert Böhm
Oct 29, 2018·Critical Care : the Official Journal of the Critical Care Forum·Sarah EitzeUNKNOWN vaccination60+ study group
May 4, 2021·Journal of Parkinson's Disease·Tiffany PhanhdoneJori Fleisher
Jul 21, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Josephine StorchUNKNOWN Vaccination 60+ Study Group

❮ Previous
Next ❯

Software Mentioned

ALERTSNet
Open Science

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.